Header Logo

Connection

Barish Edil to Pancreatic Neoplasms

Back to Details
This is a "connection" page, showing publications Barish Edil has written about Pancreatic Neoplasms.
Barish Edil
Connection Strength
9.619
Pancreatic Neoplasms
  1. Genomic and single cell sequencing facilitate the dissection of heterogeneity of pancreatic tumors. BMC Med. 2020 07 08; 18(1):177.
    View in: PubMed
    Score: 0.461
  2. Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy? J Am Coll Surg. 2018 07; 227(1):55-62.
    View in: PubMed
    Score: 0.394
  3. Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. Surg Endosc. 2018 05; 32(5):2239-2248.
    View in: PubMed
    Score: 0.382
  4. Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm. Ann Surg Oncol. 2017 Feb; 24(2):560.
    View in: PubMed
    Score: 0.353
  5. Evolving Trends Towards Minimally Invasive Surgery for Solid-Pseudopapillary Neoplasms. Ann Surg Oncol. 2016 12; 23(13):4165-4168.
    View in: PubMed
    Score: 0.352
  6. Challenges of minimally invasive pancreas surgery growth with such a high learning curve. JAMA Surg. 2015 May; 150(5):423.
    View in: PubMed
    Score: 0.322
  7. Total Laparoscopic Pancreaticoduodenectomy: A Single-Institutional Experience. Ann Surg Oncol. 2015 Dec; 22(13):4380-1.
    View in: PubMed
    Score: 0.321
  8. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram. Ann Surg. 2014 Feb; 259(2):204-12.
    View in: PubMed
    Score: 0.295
  9. Diffuse replacement of pancreatic parenchyma by intraductal papillary mucinous neoplasm. Endoscopy. 2013; 45 Suppl 2 UCTN:E407-9.
    View in: PubMed
    Score: 0.292
  10. Advancements in pancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2013 Jul; 7(5):477-90.
    View in: PubMed
    Score: 0.284
  11. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012 Nov; 36(11):1666-73.
    View in: PubMed
    Score: 0.271
  12. Neuroendocrine pancreatic tumors: guidelines for management and update. Curr Treat Options Oncol. 2012 Mar; 13(1):24-34.
    View in: PubMed
    Score: 0.259
  13. The current management of pancreatic neuroendocrine tumors. Adv Surg. 2012; 46:283-96.
    View in: PubMed
    Score: 0.256
  14. Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2. Oncologist. 2024 Aug 05; 29(8):690-698.
    View in: PubMed
    Score: 0.153
  15. Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug; 16(4):e1983.
    View in: PubMed
    Score: 0.152
  16. Combination therapies for cancer: challenges and opportunities. BMC Med. 2023 05 04; 21(1):171.
    View in: PubMed
    Score: 0.140
  17. Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. J Surg Res. 2023 04; 284:42-53.
    View in: PubMed
    Score: 0.137
  18. Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Cancer Lett. 2022 07 28; 539:215722.
    View in: PubMed
    Score: 0.131
  19. Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors. HPB (Oxford). 2022 05; 24(5):681-690.
    View in: PubMed
    Score: 0.126
  20. New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification []. Cancer Lett. 2021 10 10; 518:207-213.
    View in: PubMed
    Score: 0.124
  21. Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma. Clin Cancer Res. 2021 03 01; 27(5):1278-1286.
    View in: PubMed
    Score: 0.119
  22. Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers. Ann Surg. 2019 12; 270(6):1147-1155.
    View in: PubMed
    Score: 0.111
  23. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin a3ß1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Gastroenterology. 2020 02; 158(3):679-692.e1.
    View in: PubMed
    Score: 0.110
  24. Quality of Life Following Major Laparoscopic or Open Pancreatic Resection. Ann Surg Oncol. 2019 Sep; 26(9):2985-2993.
    View in: PubMed
    Score: 0.107
  25. Cystic pancreatic neuroendocrine tumors: A distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis. Pancreatology. 2019 Jul; 19(5):738-750.
    View in: PubMed
    Score: 0.107
  26. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells. Gastroenterology. 2019 02; 156(3):722-734.e6.
    View in: PubMed
    Score: 0.102
  27. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. J Surg Oncol. 2018 Apr; 117(5):1073-1083.
    View in: PubMed
    Score: 0.098
  28. Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2016 Feb; 39(1):18-26.
    View in: PubMed
    Score: 0.085
  29. Predictors for Surgical Referral in Patients With Pancreatic Cystic Lesions Undergoing Endoscopic Ultrasound: Results From a Large Multicenter Cohort Study. Pancreas. 2016 Jan; 45(1):51-7.
    View in: PubMed
    Score: 0.084
  30. Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2015 Aug; 150(8):701-10.
    View in: PubMed
    Score: 0.082
  31. Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study. Gastrointest Endosc. 2015 Dec; 82(6):1060-9.
    View in: PubMed
    Score: 0.081
  32. PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors. J Immunother. 2015 Jan; 38(1):1-11.
    View in: PubMed
    Score: 0.079
  33. Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1574-9.
    View in: PubMed
    Score: 0.078
  34. Laparoscopic pancreaticojejunostomy using a barbed suture: a novel technique. J Laparoendosc Adv Surg Tech A. 2014 Dec; 24(12):887-91.
    View in: PubMed
    Score: 0.078
  35. Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study. Medicine (Baltimore). 2014 Dec; 93(27):e198.
    View in: PubMed
    Score: 0.078
  36. A preclinical murine model of hepatic metastases. J Vis Exp. 2014 Sep 27; (91):51677.
    View in: PubMed
    Score: 0.077
  37. Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):458-9.
    View in: PubMed
    Score: 0.073
  38. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol. 2013 Nov; 37(11):1671-7.
    View in: PubMed
    Score: 0.073
  39. Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S725-30.
    View in: PubMed
    Score: 0.072
  40. Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):678-85.
    View in: PubMed
    Score: 0.071
  41. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT. AJR Am J Roentgenol. 2013 Mar; 200(3):563-9.
    View in: PubMed
    Score: 0.069
  42. Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. AJR Am J Roentgenol. 2013 Mar; 200(3):W283-90.
    View in: PubMed
    Score: 0.069
  43. Young patients undergoing resection of pancreatic cancer fare better than their older counterparts. J Gastrointest Surg. 2013 Feb; 17(2):339-44.
    View in: PubMed
    Score: 0.068
  44. Vaccines for pancreatic cancer. Cancer J. 2012 Nov-Dec; 18(6):642-52.
    View in: PubMed
    Score: 0.068
  45. Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literature. J Gastrointest Cancer. 2012 Sep; 43(3):431-6.
    View in: PubMed
    Score: 0.067
  46. Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning. Radiother Oncol. 2012 Aug; 104(2):167-72.
    View in: PubMed
    Score: 0.067
  47. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012 Aug; 16(8):1478-86.
    View in: PubMed
    Score: 0.066
  48. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol. 2012 Jul; 25(7):1033-9.
    View in: PubMed
    Score: 0.066
  49. Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy. Nat Rev Gastroenterol Hepatol. 2012 Feb 07; 9(4):199-208.
    View in: PubMed
    Score: 0.064
  50. Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer. J Gastrointest Surg. 2012 Apr; 16(4):753-61.
    View in: PubMed
    Score: 0.064
  51. Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma. J Surg Oncol. 2012 Jul 01; 106(1):66-71.
    View in: PubMed
    Score: 0.064
  52. Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases. Am J Surg Pathol. 2012 Feb; 36(2):235-41.
    View in: PubMed
    Score: 0.064
  53. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012 Feb; 255(2):326-33.
    View in: PubMed
    Score: 0.064
  54. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012 Feb; 36(2):173-84.
    View in: PubMed
    Score: 0.064
  55. Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. Hum Pathol. 2012 Aug; 43(8):1169-76.
    View in: PubMed
    Score: 0.064
  56. Pancreatic surgery for the radiologist, 2011: an illustrated review of classic and newer surgical techniques for pancreatic tumor resection. AJR Am J Roentgenol. 2011 Dec; 197(6):1343-50.
    View in: PubMed
    Score: 0.064
  57. Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg. 2012 Jan; 214(1):33-45.
    View in: PubMed
    Score: 0.063
  58. Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg. 2011 Nov; 146(11):1277-84.
    View in: PubMed
    Score: 0.063
  59. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012 May 15; 118(10):2674-81.
    View in: PubMed
    Score: 0.063
  60. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg. 2011 Nov; 15(11):1917-27.
    View in: PubMed
    Score: 0.063
  61. Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg. 2011 Sep; 15(9):1611-7.
    View in: PubMed
    Score: 0.062
  62. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis. Am J Surg Pathol. 2011 Jul; 35(7):981-8.
    View in: PubMed
    Score: 0.062
  63. Altered telomeres in tumors with ATRX and DAXX mutations. Science. 2011 Jul 22; 333(6041):425.
    View in: PubMed
    Score: 0.062
  64. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol. 2011 Nov; 18(12):3493-9.
    View in: PubMed
    Score: 0.061
  65. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One. 2011 Apr 29; 6(4):e19390.
    View in: PubMed
    Score: 0.061
  66. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol. 2011 Aug; 106(8):1521-6.
    View in: PubMed
    Score: 0.061
  67. Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol. 2011 Jun 01; 103(7):656-62.
    View in: PubMed
    Score: 0.060
  68. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011 Mar 04; 331(6021):1199-203.
    View in: PubMed
    Score: 0.060
  69. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc. 2011 Apr; 73(4):691-6.
    View in: PubMed
    Score: 0.059
  70. EUS-guided tattooing before laparoscopic distal pancreatic resection (with video). Gastrointest Endosc. 2010 Nov; 72(5):1089-94.
    View in: PubMed
    Score: 0.059
  71. Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Ann Surg Oncol. 2010 Dec; 17(12):3112-9.
    View in: PubMed
    Score: 0.058
  72. Preoperative endoscopic tattooing of pancreatic body and tail lesions decreases operative time for laparoscopic distal pancreatectomy. Surgery. 2010 Aug; 148(2):371-7.
    View in: PubMed
    Score: 0.057
  73. Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg. 2010 Jul; 14(7):1143-50.
    View in: PubMed
    Score: 0.057
  74. Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer). Surg Today. 2010 May; 40(5):404-10.
    View in: PubMed
    Score: 0.057
  75. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010 Mar; 251(3):470-6.
    View in: PubMed
    Score: 0.056
  76. Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):176-80.
    View in: PubMed
    Score: 0.056
  77. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol. 2010 Jan; 41(1):113-22.
    View in: PubMed
    Score: 0.055
  78. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009 Aug; 250(2):282-7.
    View in: PubMed
    Score: 0.054
  79. Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. J Am Coll Surg. 2009 May; 208(5):950-7; discussion 957-9.
    View in: PubMed
    Score: 0.053
  80. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol. 2009 Feb 01; 99(2):87-92.
    View in: PubMed
    Score: 0.052
  81. Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio. J Gastrointest Surg. 2009 Apr; 13(4):752-9.
    View in: PubMed
    Score: 0.052
  82. Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann Surg Oncol. 2008 Nov; 15(11):3199-206.
    View in: PubMed
    Score: 0.051
  83. Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience. J Gastrointest Surg. 2008 Nov; 12(11):1915-23.
    View in: PubMed
    Score: 0.050
  84. Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012 Jun; 255(6):1048-59.
    View in: PubMed
    Score: 0.016
  85. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg. 2010 Jul; 252(1):142-8.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.